Painchek Share Price and Company Fundamentals



Price
$0.05
Change
0.001 (2.041%)
52 week
0.045 - 0.105

Last traded: Last Friday at 6:10 AM

PainChek Limited develops and commercializes mobile medical device applications that provides pain assessment for individuals primarily in Australia and Europe. The company offers PainChek, which uses camera in smartphone and tablets to capture video that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited. in January 2018. PainChek Limited is based in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

4.55

Dividend yield

Beta

0.34

Market cap

$56.34M

Enterprise value

$57.45M

Company profile

Primary activitiesDevelopment and commercialisation of mobile medical applications that are intended to provide pain assessment for individuals who are unable to communicate with their carers.
Industry / SectorHealth Information Services / Healthcare
Websitehttp://www.painchek.com
Mailing address35 Lime Street Suite 401 Sydney NSW 2000 Australia
Phone / Fax1800 098 809 /
Share registryBOARDROOM PTY LIMITED

Dividends

Painchek does not pay dividends.

Company Executives

As of Sep 2021, following are the company executives and directors listed on Painchek.

NameTitleAgeTotal Pay
Mr. Philip Daffas B.Sc., M.B.A., BSc, Dip EENG, MBA, GAICDMD, CEO & Director343.57k
Mr. Ian Hobson A.C.I.S., F.C.A., M.A.I.C.D., B.BUS, FCA, ACSA, MACFO & Company Sec.55142.72k
Mr. Andrew HogganHead of Operations
Mr. Scott Robertson M.B.A.Chief Technology Officer
Prof. Jeff Hughes Ph.D.Chief Scientific Officer
Mr. David AllsoppHead of Bus. Devel. ANZ
Mr. Pete ShergillHead of Bus. Devel. UK

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-1,642.86%

Return on assets

-24.03%

Return on equity

-41.68%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Painchek is 56.34M and its enterprise value is 57.45M. The enterprise value to revenue ratio of PCK is 238.93.

The PCK's stocks Beta value is 0.34 making it 66% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Painchek (PCK)

Painchek (ASX:PCK) Frequently Asked Questions

1. What is Painchek's Stock Symbol?

Painchek trades on ASX under the ticker symbol "PCK".

2. What is Painchek's stock price today?

One share of PCK stock can currently be purchased for approximately $0.05.

3. How can I contact Painchek?

Painchek's mailing address is 35 Lime Street Suite 401 Sydney NSW 2000 Australia. The company can be reached via phone at 1800 098 809.

4. What is Painchek's official website?

The official website of Painchek is http://www.painchek.com.

5. Which share registry manages Painchek's stock?

Painchek's stock is managed by BOARDROOM PTY LIMITED.